BARCELONA, Spain and Dundee, UK, a global biopharmaceutical company focused on skin health, today announced a research collaboration with the University of Dundee, a top-ranked university in the UK in biological sciences, to develop a novel approach against chronic and debilitating dermatology diseases where itch, or pruritus, plays a dominant role. The collaboration aims to build on a proprietary immune-based treatment for chronic inflammatory conditions being developed by Dr. John Foerster’s team at the University of Dundee. The goal of the partnership is to fully control the itch associated with skin conditions and achieve a prolonged and deep therapeutic effect for patients.
The post Almirall announces a new research collaboration with the University of Dundee to develop an innovative and differentiated treatment approach for dermatological diseases appeared first on Pharma Mirror Magazine.
